Live Breaking News & Updates on Synimmune Gmbh

Stay updated with breaking news from Synimmune gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Xlife Sciences AG Publishes 2023 Annual Report - adhoc - Börsennachrichten

Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl ....

United States , Abu Dhabi , Abuz Aby , United Arab Emirates , Synimmune Gmb , Oliverr Baumann , Xlife Group , European Patent Office , Axenoll Life Sciences , Life Sciences Hub , Xlife Sciences , Department Of Health Abu Dhabi , Business Development , Operational Progress , Synimmune Gmbh , Prostate Carcinoma , Quant Biomarkers , Mint Medical , Health Abu Dhabi , Thermo Fisher Scientific , Masdar City , Financial Reports , Shareholders Meeting , Year Report ,

Xlife Sciences AG Publishes 2023 Annual Report

Xlife Sciences AG / Key word: Annual Results

Xlife Sciences AG Publishes 2023 Annual Report
23-Apr-2024 / 07:00 CET/CEST

Release of an ad hoc announcement pursuant to Art. 53 LR

The. ....

Abu Dhabi , Abuz Aby , United Arab Emirates , United States , Oliverr Baumann , Synimmune Gmb , European Patent Office , Xlife Sciences , Axenoll Life Sciences , Life Sciences Hub , Business Development , Department Of Health Abu Dhabi , Xlife Group , Operational Progress , Synimmune Gmbh , Prostate Carcinoma , Quant Biomarkers , Mint Medical , Health Abu Dhabi , Thermo Fisher Scientific , Masdar City , Financial Reports , Shareholders Meeting , Year Report ,

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline

Xlife Sciences AG / Key word: Mergers & Acquisitions/Takeover

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
29-Dec-2023 / 17:45 CET/CEST

Release of an ad hoc. ....

Christoph Antz , Oliverr Baumann , Synimmune Gmb , Xlife Sciences , Synimmune Gmbh , Acute Myeloid Leukemia , Acute Myeloid , Shareholders Meeting , Year Report ,

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten

Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to ....

Synimmune Gmb , Christoph Antz , Oliverr Baumann , Xlife Sciences , Synimmune Gmbh , Acute Myeloid Leukemia , Acute Myeloid , Shareholders Meeting , Year Report ,

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline

29.12.2023 - Xlife Sciences AG / Key word(s): Mergers & Acquisitions/Takeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29-Dec-2023 / 17:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely . Seite 1 ....

Synimmune Gmb , Xlife Sciences , Synimmune Gmbh ,